Product testing conducted by the US Food and Drug Administration (FDA) has found that many CBD-infused products on sale in the United States are mislabeled, containing vastly differing amounts of CBD than advertised on the product packaging.
The new rule was initially meant to take effect on April 1, but delays were made amid the coronavirus pandemic.
The new study could help determine how brain network patterns may change once consumers reduce their cannabis intake.
The cannabis and hemp testing company Kaycha Labs has become the first business in Florida to be awarded the state Department of Health’s certified marijuana testing laboratory status.
Taking control from July 1, the CCB will regulate the licensing and operations of the state’s cannabis companies.
New sample collectors will be allowed to collect samples of cannabis and cannabis products for testing on behalf of the state’s cannabis testing facilities.
The US state legalized the use of medical cannabis back in April 2017, but its program has yet to become fully operational.